Tag: AVeNEW
Renal Interventions’ top 10 stories of July 2024
July saw predictions of device “gold rushes”, long-term data, and new partnerships, with Ziv Haskal (University of Virginia School of Medicine, Charlottesville, USA) and...
AVeNEW trial shows superior AVF target lesion patency with covered stent...
“Study design is critically important when interpreting outcomes,” said Bart Dolmatch (Mountain View Hospital, Mountain View, USA) in his evaluation of the “disconnect” between...